NOW AVAILABLE ON-DEMAND

Compromised bone and cardiovascular health are two core issues challenging our wellness as we age, and they are particularly troubling for women.

We reach our peak bone mass in our 20s-30s. From there, it is about staving off a steady decline of our bone mass, and women's bone mass takes a sharper decline once they reach their menopausal years due to hormone changes. Meanwhile, cardiovascular issues typically develop 7 to 10 years later in women than in men, yet it is still the major mortality issue for women over 65 years.

An impressive body of clinical evidence has demonstrated that MenaQ7® Vitamin K2 as MK-7 can simultaneously support bone and cardiovascular health. Still, a growing body of research is highlighting its potential for supporting other important areas allowing women to age healthily, including pain and inflammation, and brain health. Further, we will discuss how a mother securing adequate K2 intakes also feeds into her children's health.

Sponsored By:


Speakers:

Stacey Smith, DC
Marketing and Communications Manager NORAM
Gnosis by Lesaffre

Sean Moloughney
Moderator
Editor of Nutraceuticals World